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广口瓶内剪成 l～2 mm3大小的瘤块。硬膜外针头接 1ml 注射器后抽吸瘤块，暴
露肝脏，针头穿刺入肝左叶，注入 0.1～0.2ml 瘤块，抽出针头后大棉棒压迫肝
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结论： 1、TAVE 与 TAE 治疗 VX2 肝癌相比，TAVE 在短期内会加重肝脏损伤，但
只要栓塞药物剂量控制得当，不会增加 VX2 肝癌兔死亡率。TAVE 虽然可以更好
抑制肿瘤的生长，但与 TAE 一样，不能降低肿瘤转移的发生率，不能延长 VX2
肝癌兔的总生存期。2、TAVE 联合区域恩度灌注治疗 VX2 肝癌，不加重 TAVE 对
肝功能损害，不增强 TAVE 对肝癌生长的抑制，但可降低肺转移的发生率，延长




























Chapter one：Establishment of hepatic VX2 carcinoma carrier model  
 
Objectives：The aim of this study was to establish hepatic VX2 carcinoma carrier 
model for the following research. 
 
Methods：The VX2 carcinoma which maintained in rabbit inguinal region was 
surgically taken out and minced into fine pieces about 1~2mm3 in a jia filled with 
saline water. The VX2 carcinoma tissues suctioned into a 2.5ml syringe with epidural 
needle was implanted in the left lobe of the liver in ten rabbits.  
 
Results：Nine hepatic VX2 carcinoma carrier models were successfully established. 
The tumor grew up to 1~2cm3 for 2 weeks. The VX2 tumor CT imaging demonstrated 
vascular hepatic carcinoma with manifestation of low density on plain phase, 
peripheral contrast enhancement during arterial phase and becoming hypodense on the 
portal vein phase. 
 
Conclusions：Implantation of VX2 carcinoma into the liver of rabbit successfully 
established hepatic VX2 carcinoma carrier model. The VX2 carcinoma CT imaging 
demonstrated vascular hepatic carcinoma and matches to the experimental 
requirements completely. 
 





















Chapter two：Establishment of rabbit model with hepatic artery 
and portal vein intubation 
 
Objectives：To establish rabbit model with hepatic artery and portal vein intubation . 
Improvement of operative technique and peri-operative treatment. 
 
Methods：Experiment was divided into two stages: preliminary experimental stage 
and formal experimental stage. During the first preliminary experimental phase, ten 
domestic rabbits were used to establish models. During the second preliminary 
experimental phase, ten New Zealand rabbits were used to establish models. 
 
Results：During the first preliminary experimental phase, we have mastered the 
operative technique and peri-operative treatment. During the second preliminary 
experimental phase, the based databases were assessed by statistical analysis. 8 
models were successfully established. Operation time was 41.3±12.0 min, bleeding 
volume was 11. 1±6.5 ml. None of the eight rabbits dead during the next 4 weeks . 
 
Conclusions：We can successfully establish rabbit model with hepatic artery and 
portal vein intubation by a single operator under direct vision. Better operative skills 
and attention to the details concerned with the operation are the key points to establish 
model successfully. 
 

















Chapter three：Effect of multi-devascularization combined with 
regional Endostar perfusion in the treatment of hepatic VX2 
carcinoma  
 
Objectives：To study the effect of multi-devascularization combined with regional 
Endostar perfusion in the treatment of hepatic VX2 carcinoma.  
 
Methods：46 VX2 rabbit models was randomly divided into five groups. Group A (6): 
only carried out exploratory laparotomy; GroupB(10): TAE; Group C(10): TAVE; 
GroupD(10): TAVE combined with regional Endostar perfusion. GroupE(10): 
Multi-devascularization combined with regional Endostar perfusion. The alanine 
transaminase (ALT), aspartate aminotransferase (AST), tumor growth, lung metastasis, 
and survival time were analysed. 
 
Results：The change of live function, tumor growth, lung metastasis and the result of 
survival of the five groups were as follows. First, the ALT, AST were no statistically 
significant in each group at 1 day before operation（P>0.05）. At the 3th day after 
operation, the ALT, AST of group B, C, D, E was significantly higher than that of 
group A（P<0.05）, and the ALT, AST of group C ,D, E is the highest. At the 7th day 
after operation, the ALT, AST of group B, C, D, E began to fall. But its’ were still 
higher than that of group A（P<0.05）. At the 14th day after operation, the ALT、AST 
of group A increased significantly, but the ALT, AST of group B , C, D, E still to fall. 
Second, the tumor volume were no statistically significant in each group at 1 day 
before operation（P>0.05）. Tumor size of the 5 groups were continue to grow at the 
7th day after the operation. The average tumor volume of group B, C, D, E were 
smaller than that of group A（P < 0.05）. At the 14th day after the operation, the 
average tumor volume of group B, C, D, E were still smaller than that of group A（P < 















metastasis were found in each group at 1 day before operation. And the rate of lung 
metastasis were no statistically significant in each group at the 7th day after operation
（P > 0.05）. At the 14th day after operation，the lung metastasis of groupD, E were 
less than that of groupA, B, C（P < 0.05）. Finally, the median survival time of each 
group were as follows: group A(17.33±1.09d) , group B (18.44±0.85d), group C 
(16.00±1.04d), group D (26.57±2.57d), groupE (32.63±3.64d). The survival time 
of group D, E was significantly longer than that of group A, B, C（P < 0.05）. And the 
survival time of group E was the longest. 
 
Conclusions: 
Both TAE and TAVE can aggravate the liver damage. But right amount Iodine oil 
does not hasten the death of rabbit. Both TAE and TAVE can inhibit tumor growth, 
but can't reduce the rate of lung metastasis, and can not extend the overall survival 
(OS) of VX2 liver carcinoma rabbit.  
TAVE combined with regional Endostar perfusion in the treatment of hepatic VX2 
carcinoma can reduce the rate of lung metastasis and extend the overall survival (OS) 
of VX2 liver carcinoma rabbit.  
Multi-devascularization combined with regional Endostar perfusion in the treatment 
of hepatic VX2 carcinoma worked best to extend the overall survival (OS) of VX2 
liver carcinoma rabbit. 
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